Skip to main content
Erschienen in: Supportive Care in Cancer 8/2016

18.05.2016 | Review Article

Comparison of the FACT-C, EORTC QLQ-CR38, and QLQ-CR29 quality of life questionnaires for patients with colorectal cancer: a literature review

verfasst von: Vithusha Ganesh, Arnav Agarwal, Marko Popovic, David Cella, Rachel McDonald, Sherlyn Vuong, Henry Lam, Leigha Rowbottom, Stephanie Chan, Tasneem Barakat, Carlo DeAngelis, Michael Borean, Edward Chow, Andrew Bottomley

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this review was to compare the development, characteristics, validity, and reliability of three widely used quality of life (QOL) assessment tools used in colorectal cancer (CRC) patients: the Functional Assessment of Cancer Therapy-Colorectal (FACT-C), the European Organization for Research and Treatment of Cancer Quality of Life (EORTC) Quality of Life Questionnaire Colorectal Cancer Module (QLQ-CR38) and its successor, the QLQ-CR29.

Methods

A literature search was conducted using Ovid EMBASE and EMBASE Classic (1996–2015 Week 39), Ovid MEDLINE and OLDMEDLINE (1996 September Week 4 2015), and the Cochrane Central Register of Controlled Trials (up to August 2015) to identify studies that discussed the FACT-C, EORTC QLQ-CR38, and QLQ-CR29 including, but not limited to, their development, characteristics, validity, and reliability.

Results

The FACT-C consists of 36 items, presented on a 5-point Likert scale, in four domains of well-being (physical, emotional, social, and functional), and the Colorectal Cancer Subscale (CCS). The physical and social well-being scales showed reasonable internal consistency (Cronbach’s alpha coefficient > 60) in all studied populations. The EORTC QLQ-CR38 (38 items) and the QLQ-CR29 (29 items) are implemented in conjunction with the core QLQ-C30 (30 items); all are presented in 4-point Likert scales. Seven scales in the QLQ-CR38 demonstrated good internal consistency (Cronbach’s alpha coefficient > 0.70). In the QLQ-CR29, three scales had a Cronbach’s alpha coefficient of less than 0.70.

Conclusion

The FACT-C, QLQ-CR38, and QLQ-CR29 have been extensively validated. However, analysis of their characteristics, validity, and reliability suggest differing suitability in assessing QOL in specific clinical situations.
Literatur
1.
Zurück zum Zitat Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRefPubMed Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRefPubMed
2.
Zurück zum Zitat Marventano S, Forjaz MJ, Grosso G, Mistretta A, Giorgianni G, Platania A et al (2013) Health related quality of life in colorectal cancer patients: state of the art. BMC Surg 13(Suppl 2):S15CrossRefPubMedPubMedCentral Marventano S, Forjaz MJ, Grosso G, Mistretta A, Giorgianni G, Platania A et al (2013) Health related quality of life in colorectal cancer patients: state of the art. BMC Surg 13(Suppl 2):S15CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Popovic M, Nguyen J, Chen E, Di Giovanni J, Zeng L, Chow E (2012) Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases. Expert Rev Pharmacoecon Outcome Res 12(2):213–219CrossRef Popovic M, Nguyen J, Chen E, Di Giovanni J, Zeng L, Chow E (2012) Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases. Expert Rev Pharmacoecon Outcome Res 12(2):213–219CrossRef
4.
Zurück zum Zitat Ward WL, Hahn EA, Mo F, Hernandez L, Tulsky DS, Cella D (1999) Reliability and validity of the functional assessment of cancer therapy-colorectal (FACT-C) quality of life instrument. Qual Life Res 8:181–195CrossRefPubMed Ward WL, Hahn EA, Mo F, Hernandez L, Tulsky DS, Cella D (1999) Reliability and validity of the functional assessment of cancer therapy-colorectal (FACT-C) quality of life instrument. Qual Life Res 8:181–195CrossRefPubMed
5.
Zurück zum Zitat Gotay CC (2004) Assessing cancer-related quality of life across a spectrum of applications. J Natl Cancer Inst Monogr 33:126–133CrossRefPubMed Gotay CC (2004) Assessing cancer-related quality of life across a spectrum of applications. J Natl Cancer Inst Monogr 33:126–133CrossRefPubMed
6.
7.
Zurück zum Zitat Aaronson NK, Ahmedzaie S, Bergman B, for the European Organization for Research and Treatment of Cancer Study Group on Quality of Life et al (1993) The EORTC QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMed Aaronson NK, Ahmedzaie S, Bergman B, for the European Organization for Research and Treatment of Cancer Study Group on Quality of Life et al (1993) The EORTC QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMed
8.
Zurück zum Zitat Cella DF, Tulsky D, Gray G, Saraflan B, Linn E et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579PubMed Cella DF, Tulsky D, Gray G, Saraflan B, Linn E et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579PubMed
9.
Zurück zum Zitat Sprangers MAG, te Velde A, Aaronson NK (1999) Construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). Eur J Cancer 35(2):238–247CrossRefPubMed Sprangers MAG, te Velde A, Aaronson NK (1999) Construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). Eur J Cancer 35(2):238–247CrossRefPubMed
10.
Zurück zum Zitat Gujral S, Conroy T, Fleissner C, Sezer O, King PM, Avery KNL et al (2007) Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire. Eur J Cancer 43:1564–1573CrossRefPubMed Gujral S, Conroy T, Fleissner C, Sezer O, King PM, Avery KNL et al (2007) Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire. Eur J Cancer 43:1564–1573CrossRefPubMed
11.
Zurück zum Zitat Hopwood P (1992) Body image. Internal report of the EORTC Study Group of Quality of Life, Manchester, U.K Hopwood P (1992) Body image. Internal report of the EORTC Study Group of Quality of Life, Manchester, U.K
12.
Zurück zum Zitat Yoo HJ, Kim JC, Eremenco S, Han OS (2005) Quality of life in colorectal cancer patients with colectomy and validation of the functional assessment of cancer therapy-colorectal (FACT-C), version 4. J Pain Manag 3(1):24–32CrossRef Yoo HJ, Kim JC, Eremenco S, Han OS (2005) Quality of life in colorectal cancer patients with colectomy and validation of the functional assessment of cancer therapy-colorectal (FACT-C), version 4. J Pain Manag 3(1):24–32CrossRef
13.
Zurück zum Zitat Rotunda C, Conroy T, Mercier M, Bonnetain F, Uwer L, Miny J et al (2008) Validation of the French version of the colorectal-specific quality of life questionnaires EORTC QLQ-CR38 and FACT-C. Qual Life Res 17:437–445CrossRef Rotunda C, Conroy T, Mercier M, Bonnetain F, Uwer L, Miny J et al (2008) Validation of the French version of the colorectal-specific quality of life questionnaires EORTC QLQ-CR38 and FACT-C. Qual Life Res 17:437–445CrossRef
14.
Zurück zum Zitat Wong CK, Lam CL, Law WL, Poon JT, Chan P, Kwong DL et al (2012) Validity and reliability study on traditional Chinese FACT-C in Chinese patients in colorectal neoplasm. J Eval Clin Pract 18(6):1186–95CrossRefPubMed Wong CK, Lam CL, Law WL, Poon JT, Chan P, Kwong DL et al (2012) Validity and reliability study on traditional Chinese FACT-C in Chinese patients in colorectal neoplasm. J Eval Clin Pract 18(6):1186–95CrossRefPubMed
15.
Zurück zum Zitat Kong D, Yang Z, Wang Y, Meng Q, Tang X, Cun Y et al (2012) Development and validation of a simplified Chinese version of EORTC QLQ-CR38 to measure the quality of life of patients with colorectal cancer. Oncology 83(4):201–9CrossRefPubMed Kong D, Yang Z, Wang Y, Meng Q, Tang X, Cun Y et al (2012) Development and validation of a simplified Chinese version of EORTC QLQ-CR38 to measure the quality of life of patients with colorectal cancer. Oncology 83(4):201–9CrossRefPubMed
16.
Zurück zum Zitat Law CC, Lam WWT, Fu YT, Wong KH, Sprangers MAG, Fiedling R (2008) Validation of the Chinese version of the EORTC colorectal cancer-specific quality-of-life questionnaire module (QLQ-CR38). J Pain Manag 35(2):203–213CrossRef Law CC, Lam WWT, Fu YT, Wong KH, Sprangers MAG, Fiedling R (2008) Validation of the Chinese version of the EORTC colorectal cancer-specific quality-of-life questionnaire module (QLQ-CR38). J Pain Manag 35(2):203–213CrossRef
17.
Zurück zum Zitat Thaysen HV, Jess P, Laurberg S, Groenvold M (2012) Validation of the Danish version of the disease specific instrument EORTC QLQ-CR38 to assess health-related quality of life in patients with colorectal cancer. Health Qual Life Outcomes 10:150CrossRefPubMedPubMedCentral Thaysen HV, Jess P, Laurberg S, Groenvold M (2012) Validation of the Danish version of the disease specific instrument EORTC QLQ-CR38 to assess health-related quality of life in patients with colorectal cancer. Health Qual Life Outcomes 10:150CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Whistance RN, Conroy T, Chie W, Costantini A, Sezer O, Koller M et al (2009) Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer 45:3017–3026CrossRefPubMed Whistance RN, Conroy T, Chie W, Costantini A, Sezer O, Koller M et al (2009) Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer 45:3017–3026CrossRefPubMed
19.
Zurück zum Zitat Arraras JI, Suarez J, de la Vega FA, Vera R, Asin G, Arrazubi V, Rico M et al (2011) The EORTC quality of life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanish patients. Clin Transl Oncol 13:50–56CrossRefPubMed Arraras JI, Suarez J, de la Vega FA, Vera R, Asin G, Arrazubi V, Rico M et al (2011) The EORTC quality of life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanish patients. Clin Transl Oncol 13:50–56CrossRefPubMed
20.
Zurück zum Zitat Nowak W, Tobiasz-Adamczyk B, Brzyski P, Salowka J, Kulis D, Richter P (2011) Adaptation of quality of life module EORTC QLQ-CR29 for Polish patients with rectal cancer-initial assessment of validity and reliability. Pol Przegl Chir 83(9):502–510PubMed Nowak W, Tobiasz-Adamczyk B, Brzyski P, Salowka J, Kulis D, Richter P (2011) Adaptation of quality of life module EORTC QLQ-CR29 for Polish patients with rectal cancer-initial assessment of validity and reliability. Pol Przegl Chir 83(9):502–510PubMed
21.
Zurück zum Zitat Salsman JM, Cella D, Vergo MT, Yount SE (2014) Multidisciplinary approach to quality of life. In: Thomas CR Jr (ed) Cancers of the colon and rectum: a multidisciplinary approach to diagnosis and management. Demos Medical Publishing, New York, pp 247–261 Salsman JM, Cella D, Vergo MT, Yount SE (2014) Multidisciplinary approach to quality of life. In: Thomas CR Jr (ed) Cancers of the colon and rectum: a multidisciplinary approach to diagnosis and management. Demos Medical Publishing, New York, pp 247–261
22.
Zurück zum Zitat Wong CK, Chen J, Yu CLY, Sham M, Lam CLK (2015) Systematic review recommends the European Organization for Research and Treatment of Cancer colorectal cancer-specific module for measuring quality of life in colorectal cancer patients. J Clin Epidemiol 68:266–278CrossRefPubMed Wong CK, Chen J, Yu CLY, Sham M, Lam CLK (2015) Systematic review recommends the European Organization for Research and Treatment of Cancer colorectal cancer-specific module for measuring quality of life in colorectal cancer patients. J Clin Epidemiol 68:266–278CrossRefPubMed
23.
Zurück zum Zitat Uwer L, Rotonda C, Guillemin F, Miny J, Karninsky M, Mercier M et al (2011) Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer. Health Qual Life Outcomes 9:70CrossRefPubMedPubMedCentral Uwer L, Rotonda C, Guillemin F, Miny J, Karninsky M, Mercier M et al (2011) Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer. Health Qual Life Outcomes 9:70CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Pullmer R, Linden W, Rnic K, Vodermaier A (2014) Measuring symptoms in gastrointestinal cancer: a systematic review of assessment instruments. Support Care Cancer 22:2941–2955CrossRefPubMed Pullmer R, Linden W, Rnic K, Vodermaier A (2014) Measuring symptoms in gastrointestinal cancer: a systematic review of assessment instruments. Support Care Cancer 22:2941–2955CrossRefPubMed
25.
Zurück zum Zitat Wong CK, Lam CLK, Mulhern B, Law W, Poon JTC, Knowng DLW (2013) Measurement invariance of the functional assessment of cancer therapy-colorectal quality-of-life instrument among modes of administration. Qual Life Res 22:1415–1426CrossRefPubMed Wong CK, Lam CLK, Mulhern B, Law W, Poon JTC, Knowng DLW (2013) Measurement invariance of the functional assessment of cancer therapy-colorectal quality-of-life instrument among modes of administration. Qual Life Res 22:1415–1426CrossRefPubMed
26.
Zurück zum Zitat Yost KJ, Cella D, Chawla A, Holmgren E, Eton DT, Ayanian JZ et al (2005) Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches. J Clin Oncol 58:1241–1251 Yost KJ, Cella D, Chawla A, Holmgren E, Eton DT, Ayanian JZ et al (2005) Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches. J Clin Oncol 58:1241–1251
27.
Zurück zum Zitat Wilson TR, Birks Y, Alexander DJ (2013) Pitfalls in the interpretation of standardized quality of life instruments for individual patients? A qualitative study in colorectal cancer. Qual Life Res 22:1879–1888CrossRefPubMed Wilson TR, Birks Y, Alexander DJ (2013) Pitfalls in the interpretation of standardized quality of life instruments for individual patients? A qualitative study in colorectal cancer. Qual Life Res 22:1879–1888CrossRefPubMed
Metadaten
Titel
Comparison of the FACT-C, EORTC QLQ-CR38, and QLQ-CR29 quality of life questionnaires for patients with colorectal cancer: a literature review
verfasst von
Vithusha Ganesh
Arnav Agarwal
Marko Popovic
David Cella
Rachel McDonald
Sherlyn Vuong
Henry Lam
Leigha Rowbottom
Stephanie Chan
Tasneem Barakat
Carlo DeAngelis
Michael Borean
Edward Chow
Andrew Bottomley
Publikationsdatum
18.05.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2016
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3270-7

Weitere Artikel der Ausgabe 8/2016

Supportive Care in Cancer 8/2016 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.